🔗 Permalink

Inventor profile of:

Nicholas Erho

City:

Vancouver

Country:

Canada

Published Applications:

Last publication date:

2025-05-29

Top Assignees for applications by Nicholas Erho

The entities that hold a legal rights for patent applications filed by inventor Erho Nicholas:

Decipher Biosciences, Inc. 4 San Diego, CA United States
The University of British Columbia 1 Vancouver, Canada
2. The Regents of the University of Michigan 1 Ann Arbor, MI United States

Recent patent applications by Erho Nicholas

Nicholas Erho from Vancouver, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-05-29

US20250171854A1

Chemistry; metallurgy

GENETIC SIGNATURES TO PREDICT PROSTATE CANCER METASTASIS AND IDENTIFY TUMOR AGGRESSIVENESS

#2 | 2024-12-19

US20240417800A1

Chemistry; metallurgy

USE OF A GENETIC SIGNATURE DIAGNOSTICALLY TO EVALUATE TREATMENT STRATEGIES FOR PROSTATE CANCER

#3 | 2024-10-31

US20240360517A1

Chemistry; metallurgy

SUBTYPING PROSTATE CANCER TO PREDICT RESPONSE TO HORMONE THERAPY

#4 | 2023-05-18

US20230151429A1

Chemistry; metallurgy

USE OF GENOMIC SIGNATURES TO PREDICT RESPONSIVENESS OF PATIENTS WITH PROSTATE CANCER TO POST-OPERATIVE RADIATION THERAPY

#5 | 2022-10-13

US20220325352A1

Chemistry; metallurgy

MOLECULAR SUBTYPING, PROGNOSIS, AND TREATMENT OF BLADDER CANCER

#6 | 2022-06-09

US20220177974A1

Chemistry; metallurgy

GENETIC SIGNATURES TO PREDICT PROSTATE CANCER METASTASIS AND IDENTIFY TUMOR AGGRESSIVENESS

#7 | 2021-05-06

US20210130902A1

Chemistry; metallurgy

Subtyping prostate cancer to predict response to hormone therapy

#8 | 2019-07-18

US20190218621A1

Chemistry; metallurgy

Use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapy

#9 | 2019-07-04

US20190204322A1

Physics

MOLECULAR SUBTYPING, PROGNOSIS AND TREATMENT OF PROSTATE CANCER

#10 | 2019-01-17

US20190017123A1

Chemistry; metallurgy

Genetic signatures to predict prostate cancer metastasis and identify tumor aggressiveness

#11 | 2018-10-11

US20180291459A1

Chemistry; metallurgy

USE OF A GENETIC SIGNATURE DIAGNOSTICALLY TO EVALUATE TREATMENT STRATEGIES FOR PROSTATE CANCER

#12 | 2018-08-02

US20180216197A1

Chemistry; metallurgy

Molecular subtyping, prognosis, and treatment of bladder cancer

InventorID:

2257705 ⎘